South & Central America Infusion Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.
No. of Pages: 180 | Report Code: BMIRE00032022 | Category: Life Sciences
No. of Pages: 180 | Report Code: BMIRE00032022 | Category: Life Sciences
The South & Central America infusion devices market size is expected to reach US$ 1,164.42 million by 2031 from US$ 722.52 million in 2023. The market is estimated to record a CAGR of 6.1% from 2023 to 2031.
The South and Central America infusion devices market is segmented into Brazil, Argentina, and the Rest of South and Central America. The recent technological developments have had a direct impact on the economy of Brazil which has mostly advanced. Advantages such as cost-effectiveness and higher work efficiencies are cited as the major attracting points for manufacturing companies to establish bases in South America. The South and Central American infusion devices market is characterized by the presence of several key players striving to expand their market share through strategic initiatives such as product innovations, partnerships, and regional expansions. Major companies operating in this market include Abbott, B. Braun Melsungen AG, Baxter International Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medline Industries, Inc., and Medtronic. These companies are focusing on enhancing their product portfolios and strengthening their distribution networks to cater to the growing demand for infusion devices in the region. For instance, the South & Central America insulin infusion pump market is projected to grow at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2030. This competitive landscape is further influenced by factors such as technological advancements, regulatory developments, and the increasing prevalence of chronic diseases, which collectively drive the demand for advanced infusion therapies in South and Central America.
Key segments that contributed to the derivation of the South & Central America infusion devices market analysis are product type, infusion pumps, infusion sets, application, and end user.
Various market players focus on strategic developments such as product launches, mergers, acquisitions, and collaborations to develop advanced products that ease the treatment of chronic disorders such as diabetes, cancer, and chronic pain. The following are a few recent developments in the South & Central America infusion devices market. In February 2023, Mindray launched its BeneFusion i Series and u Series infusion systems, featuring high precision, adaptive customization and extraordinary simplicity for guaranteed levels of medication safety in a variety of clinical settings. In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes Agilia Volumetric Pump and Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021. In January 2021, Eitan Medical, a global leader in advanced infusion therapy, launched a UK operation to improve its support of Sapphire infusion pump customers, which include NHS Trusts, private hospitals, and home care providers. An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future.
Based on country, the South & Central America infusion devices market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2023.
According to an article published in Diabetology and Metabolic Syndrome in October 2020, Brazil is one of the top 10 countries with the highest number of diabetes mellitus cases, affecting 16.8 million people. This rising diabetes prevalence translated into a 60% growth in the related risk ratio for cardiovascular diseases associated with diabetes, driving the demand for infusion pumps in Brazil. Moreover, local players such as Lifemed S.A, are majorly focusing on the development of new products to garner them along with the international market share and strengthen their establishment in the Brazilian market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 722.52 Million |
| Market Size by 2031 | US$ 1,164.42 Million |
| Global CAGR (2023 - 2031) | 6.1% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
Some of the key players operating in the market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The South & Central America Infusion Devices Market is valued at US$ 722.52 Million in 2023, it is projected to reach US$ 1,164.42 Million by 2031.
As per our report South & Central America Infusion Devices Market, the market size is valued at US$ 722.52 Million in 2023, projecting it to reach US$ 1,164.42 Million by 2031. This translates to a CAGR of approximately 6.1% during the forecast period.
The South & Central America Infusion Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Infusion Devices Market report:
The South & Central America Infusion Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Infusion Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Infusion Devices Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Infusion Devices Market
